Normalization of oxidative stress parameters after kidney transplant is secondary to full recovery of renal function

Clinical Nephrology

Volumn 62, Issue 2, 2004, Pages 131-137

  Antolini, Francesco ^a,c   Valente, F ^b   Ricciardi, D ^b   Fagugli, R M ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Ospedale Silvestrini   (Italy)

^c ENEA Materials Sci/Technology Unit   (Italy)

Author keywords

AGEs; AOPP; Carbonyls; Kidney transplant; Pentosidine; Total antioxidant power

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALBUMIN; AZATHIOPRINE; CARBONYL DERIVATIVE; CREATININE; CYCLOSPORIN; OXYGEN RADICAL; PENTOSIDINE; PREDNISONE; PROTEIN; STEROID; URIC ACID;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MOLECULAR WEIGHT; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; REMISSION;

EID: 4444227471     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp62131     Document Type: Article

References (27)

1. Benzie IF, Strain JJ 1996 The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Annal Biochem 239: 70-76.
2. Cao G Verdon CP, Wu AHB et al 1995 Automated assay of oxygen radical absorbance capacity with the COBAS FARA II. Clin Chem 41: 1738-1744
3. Cao G, Prior RL 1999 Measurement of oxygen radical absorbance capacity in biological samples. Methods Enzymol 299: 50-62
4. Chang JCF, Ulrich PC, Bucala R, Cerami A 1985 Detection of an advanced glycosylation product bound to protein in situ. J Biol Chem 260: 7970-1914
5. Clermont G, Lecour S, Lahet J et al 2000 Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients. Cardiovasc Res 47: 618-623
6. Dean TR, Fu S, Stocker R, Davies MJ 1997 Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 324: 1-18
7. Filipe P. Haigle J, Freitas J, Fernandes A, Maziere JC, Maziere C, Santus R, Morliere P 2002 Anti- and pro-oxidant effects of urate in copper-induced low-density lipoprotein oxidation. Eur J Biochem 269: 5474-5483
8. Floridi A, Trizza V, Paolotti P, Lucarelli C 1999 Analytical strategy for the assessment of the protein glycation status in uremic patients by high-performance liquid chromatography. J Chromatogr A 846: 65-71
9. Franse LV, Pahor M, Di Bari M, Shorr RI, Wan JY, Somes GW, Applegate WB 2000 Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program. J Hypertens 18: 1149-1154
10. Hricik DE, Schulak JA, Sell DR et al 1993 Effects of kidney or kidney-pancreas transplantation on plasma pentosidine. Kidney Int 43: 398-403
11. Jackson P, Loughrey CM, Lightbody JH et al 1995 Effect of hemodialysis of total antioxidant capacity and serum antioxidants inpatients with chronic renal failure. Clin Chem 41: 1135-1138
12. Johnson RJ, Kang DH, Feig D et al 2003 Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41: 1183-1190
13. Martin-Mateo M, Sanchez-Portugal M, Iglesias S, et al 1999 Oxidative stress in chronic renal failure. Ren Fail 21: 155-167
14. Miyata T, Ueda Y, Yoshida A et al 1997 Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy. Kidney Int 51: 880-887
15. Miyata T, Ueda Y, Yamada Y et al 1998 Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia. J Am Soc Nephrol 9: 2349-2356
16. Miyata T van Ypersele de Strihou C, Kurokawa K, Baynes JW 1999 Alterations in nonenzymatic bio-chemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int 55: 389-399
17. Miyata T, Kurokawa K, van Ypersele de Strihou C 2000 Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J Am Soc Nephrol 11: 1744-1752
18. Miyata T, Ueda Y, Saito A, Kurosawa K 2000 "Carbonyl stress" and dialysis-related amyloidosis. Nephrol Dial Transplant 15 (Suppl 1): 25-28
19. Nguyen-Khoa T, Massy ZA, Witko-Sarsat V et al 1999 Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients. Kidney Int 56: 747-753
20. Raj DSC, Choudhury D, Welbourne TC, Levi M 2000 Advanced glycation end products: a nephrologist's perspective. Am J Kidney Dis 35: 365-380
21. Teng RJ, Ye YZ, Parks DA, Beckmen JS 2002 Urate produced during hypoxia protects heart proteins from peroxinitrite-mediated protein nitration. Free Radic Biol Med 33: 1243-1249
22. Verdeechia P, Schillaci G, Reboldi GP, Santeusanio F, Porcellati C, Brunetti P 2000 Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study. Hypertension 36: 1072-1078
23. Vlassara H 1996 Advanced glycation end products and atherosclerosis. Ann Med 28: 419-426
24. Wada T, Miyata T, Kurokawa K 1999 Implication of carbonyl stress in long-term uraemic complications. Nephrol Dial Transplant 14 (Suppl 1): 79-81
25. Waring WS, Convery A, Mishra V, Shenkin A, Webb DJ, Maxwell SR 2003 Uric acid reduces exercise-induced oxidative stress in healthy adults. Clin Sci (Lond) 105: 425-430
26. Witko-Sarsat V, Friedlander M, Khoa TN et al 1998 Advanced oxidation protein products as a novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161: 2524-2532
27. Witko-Sarsat V, Nguyen-Khoa P, Jungers P et al 1999 Advanced oxidation protein products as a novel basis of oxidative stress in uraemia. Nephrol Dial Transplant 14 (Suppl 1): 76-78